BlackRock’s Disc Medicine IRON Stock Holding History
Bought
Maintained
Sold
Other funds holding IRON
BlackRock's IRON Position: Q3 2026 in Review
BlackRock increased its Disc Medicine (IRON) stake by 2.6% in Q3 2026, buying an estimated $4.91M and bringing the position to 2,532,863 shares worth $166M. The position accounts for ﹤0.01% of the portfolio, ranked #1875.
BlackRock first reported a position in IRON in Q1 2021 and has held it in 23 quarters since. The position peaked at $181M in Q4 2025. 236 funds tracked by Wall St. Rank hold IRON as of Q3 2026.
- BlackRock held 2,532,863 shares of Disc Medicine worth $166M as of Q3 2026.
- BlackRock bought 64,964 Disc Medicine shares in Q3 2026, an estimated $4.91M.
- Disc Medicine made up ﹤0.01% of BlackRock's portfolio in Q3 2026, its #1875 holding.
- BlackRock first reported a position in Disc Medicine in Q1 2021 and has held it in 23 quarters since.
- BlackRock's Disc Medicine position peaked at $181M in Q4 2025.
- 236 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.
Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.